EUVIMEDEUVIMED entdecken
Crossref

Clinical Research in Portugal and the Importance of Case Reports

João Pedro Ferreira

SPMI CASE REPORTS · 14.11.2024

DOI: 10.60591/crspmi.355 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SPMI CASE REPORTS, erschienen am 14.11.2024. Verfasst von João Pedro Ferreira.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Contemporary medicine is based on data.We use data to guide our clinical decisions on a daily basis.From rather simple routine things such as using a formula to estimate the glomerular filtration rate to compute a calcium score based on computed tomography angiography to guide statin treatment intensity.Such a data-rich environment will likely increase in the near future as artificial intelligence (AI)-based tools become widely available (e.g., AI supporting for image interpretation, text mining, risk decision tools, etc.).Of course, the use of data in contemporary medicine is backed by large-scale clinical trials enrolling hundreds or thousands of participants comparing a new ("active") treatment versus a placebo.However, such an enterprise model is far from healthy.As the model is backed by private companies spending millions on large-scale trials testing new treatments, the model is intended to maximize profit.As such, comparisons with older and cheaper treatments, comparative effectiveness studies, or lifestyle interventions are undertested, underfunded, and underperformed.The problem with this current model is that health-care systems may be spending much more than they should on treatments that may add little benefit to existing ones and patients are not receiving the best support from the health care system, for example regarding health prevention strategies and risk-based interventions.Only investigator-led clinical trials can overcome these barriers with more pragmatic, patient-centered clinical trials.However, currently, Portugal does not have a dedicated strategy nor funding for investigator-led clinical trials and, beyond the potential excessive expenditure on healthcare resources, Portuguese patients are being treated solely on the basis of imported information from other populations.Moreover, Portuguese clinicians are seldom given the opportunity to perform clinical research and enhance their careers through clinical research.These issues have been detailed in a paper written by myself and others. 1 Beyond the aforementioned limitations and roadblocks, information from randomized clinical trials presents average effects and does not provide an answer for all individual patients nor all the clinical scenarios.Often, clinicians have to use their judgment and knowledge to try and solve clinical problems in a

Schlagwörter

clinical researchPortugal

Zitieren

APA

Ferreira, J. P. (2024). Clinical Research in Portugal and the Importance of Case Reports. SPMI CASE REPORTS. https://doi.org/10.60591/crspmi.355

Vancouver

Ferreira JP. Clinical Research in Portugal and the Importance of Case Reports. SPMI CASE REPORTS. 2024. doi:10.60591/crspmi.355

BibTeX
@article{Ferreira2024,
  author = {Ferreira, João Pedro},
  title = {Clinical Research in Portugal and the Importance of Case Reports},
  journal = {SPMI CASE REPORTS},
  year = {2024},
  doi = {10.60591/crspmi.355}
}
Kostenlos starten →